Azzeddine Charki | Neuropsychology | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Azzeddine Charki | Neuropsychology | Best Researcher Award 

Dr. Azzeddine Charki is a Professor of Cognitive and Biological Psychology at the Faculty of Letters and Human Sciences Aïn Chock, Hassan II University, Casablanca. He holds a Ph.D. in Neuropsychology from Sidi Mohamed Ben Abdellah University, Fez. Dr. Charki is an esteemed researcher and active member of the Laboratory for Studies and Research in Cognitive and Human Sciences, focusing on psychology and language. With a strong dedication to cognitive psychology and neuropsychology, he supervises numerous research projects and contributes significantly to academic discourse. He has authored and co-authored several publications in high-impact journals on topics such as executive function, mentalizing, and neurodevelopmental disorders like ASD and ADHD. Fluent in Arabic, French, and English, he integrates pedagogical expertise with rigorous data analysis and project management. Dr. Charki’s commitment to advancing psychological science is matched by his passion for mentoring and fostering academic growth in his field.

Profile

🎓 Education

Dr. Azzeddine Charki earned his Ph.D. in Neuropsychology from Sidi Mohamed Ben Abdellah University, Fez. His doctoral work laid the foundation for his deep specialization in neuropsychology and cognitive sciences, particularly in executive function and mentalizing. Throughout his academic training, he developed a multidisciplinary understanding of brain-behavior relationships, integrating biological, cognitive, and social perspectives. His education emphasized both theoretical models and practical application in clinical and developmental contexts. Dr. Charki also received training in pedagogy, research methodology, and advanced data analysis techniques, which he continues to use in his academic career. His strong educational background has enabled him to contribute to Moroccan and international scholarship in cognitive and neuropsychology. His academic formation has also nurtured a strong inclination toward interdisciplinary research and collaborative knowledge production, particularly in the study of social cognition and neurodevelopmental disorders such as autism and ADHD.

🧪 Experience

Dr. Azzeddine Charki began his academic career as a Temporary Professor at Sidi Mohamed Ben Abdellah University, Fez (2020–2022), where he taught and conducted research in cognitive and neuropsychology. Since November 2023, he has been serving as Assistant Professor at the Faculty of Letters and Human Sciences Aïn Chock, Hassan II University, Casablanca. Over the years, he has supervised numerous undergraduate and postgraduate research projects and participated in collaborative initiatives within the university’s Laboratory for Studies and Research in Cognitive and Human Sciences. In addition to his teaching responsibilities, Dr. Charki has contributed extensively to the academic literature with a focus on executive functioning, theory of mind, and developmental psychopathology. His professional experience also includes project management, scientific writing, and dissemination of research findings. His bilingual and multicultural skills have allowed him to reach a wide range of students and researchers across Arabic, Francophone, and Anglophone academic contexts.

🏅 Awards and Honors

Dr. Azzeddine Charki has earned recognition primarily through his impactful research publications and academic service in Morocco’s leading institutions. Although specific named awards were not detailed, his repeated inclusion in peer-reviewed international and regional journals such as Applied Neuropsychology: Child, Neuropsychiatry and Neuropsychology, and the Arab Journal of Psychology signifies scholarly acknowledgment of his research excellence. His work on autism spectrum disorder, theory of mind, and executive functions reflects high intellectual merit and contributes meaningfully to both theoretical understanding and practical applications in neuropsychology. Dr. Charki’s mentorship of numerous student research projects and his active engagement in cross-disciplinary studies also underscore his standing as a respected academic. Being a core member of a cognitive science laboratory at Hassan II University further testifies to his leadership in scientific inquiry and academic collaboration. These contributions collectively demonstrate his respected status and growing impact in the field of cognitive psychology and neurodevelopmental research.

🔬 Research Focus

Dr. Charki’s research centers on cognitive psychology and neuropsychology, with particular interest in executive functions, social cognition, and neurodevelopmental disorders. He investigates mentalizing processes, especially the cognitive and affective domains of theory of mind in children with Autism Spectrum Disorder (ASD). His work explores both typical and atypical development, aiming to identify neural and behavioral mechanisms underlying disorders such as ASD and ADHD. He also delves into comparative frameworks across schizophrenia spectrum disorders, highlighting the neurobiological overlap in social cognition deficits. Dr. Charki integrates developmental psychology, neurobiology, and psychometric assessments to explore how children’s cognitive representations are structured and evolve in different socio-cultural contexts. His scholarly publications demonstrate a strong methodological foundation and innovative contributions to understanding how executive functions interact with social behavior. Furthermore, he actively examines Moroccan sociocultural representations in educational contexts, blending qualitative and quantitative approaches to enrich cognitive psychological theory and practice.

✅ Conclusion

Dr. Azzeddine Charki is a dedicated cognitive psychologist whose interdisciplinary research on executive function, mentalizing, and neurodevelopmental disorders enhances both scientific understanding and educational practice through a culturally grounded and evidence-based approach.

Publications

  • Charki, A., Zarbouch, B., Bouchala, C., & Meklaui, F., Z . (2024). Neuronal and developmental dimensions of mentalizing and it’s connection with executive functions. Arab Journal of Psychology. https://doi.org/10.57642/AJOPSY911

 

  • Charki, A., Meklaoui, F. Z., Charki, A., & Ettouzani, A. (2025). Examining the association between variation of ASD and cognitive and affective domains of mentalizing in verbal children with ASD. Applied Neuropsychology: Child, 1–11. https://doi.org/10.1080/21622965.2025.2504502

 

 

 

 

 

 

Wei Jiang | Cognitive and neuropathology | Women Researcher Award

Published on by Cognitive Scientist Awards

 Dr. Wei Jiang | Cognitive and neuropathology | Women Researcher Award

Medical University of South Carolina , United States

Her academic focus includes microbiome, B cell/autoantibody interactions, and disease pathogenesis, with particular emphasis on HIV, addictive drugs, and systemic lupus erythematosus (SLE). She is involved in several clinical and translational research projects, including R01DA059854 (Jiang & Sheng), investigating the impacts of drug abuse on autoantibodies and immune reconstitution in HIV. She also works on CSRD Merit I01 CX002422, exploring B cell-mediated immunological failure in HIV-infected individuals on antiretroviral therapy. Additionally, she contributes to NIDA-funded studies, such as R01DA055523, examining the oral microbiome’s effect on cognition in HIV-infected cannabis users, and R01DA059538, investigating HIV persistence in cocaine users. Furthermore, she collaborates on a Translational Science Award project exploring the oral microbiome’s impact on cognition in Alzheimer’s disease.

 

 

Profile

Education:

She earned her M.S. in Epidemiology and Biostatistics from Case Western Reserve University, Medical School, Cleveland, USA, in 2012. Prior to that, she completed a Postdoctoral fellowship at Case Western Reserve University, Medical School, Cleveland, USA, in 2008. She holds an M.S. in Immunology from Capital Medical University, Beijing, China, which she completed in 2001. She also received her M.D. in Internal Medicine from Capital Medical University, Beijing, China, in 1997.

BRIEF RESEARCH INTEREST STATEMENT:

She has 8 years of clinical experience in infectious diseases and 22 years of translational research experience in disease immunopathogenesis. As a corresponding author, she has published 52 peer-reviewed articles on microbiome and disease immunopathogenesis in high-profile journals like Microbiome, Arthritis & Rheumatology, J Autoimmunity, and EbioMedicine, bringing her total number of peer-reviewed publications to 101. As a physician-scientist, she has served as Principal Investigator on five R01 grants from NIAID or NIDA, along with a VA clinical merit grant, focusing on microbiomes, drug abuse, autoimmunity, and HIV immunopathogenesis. Her research primarily focuses on two major areas. The first is understanding the role of B cell perturbation and autoantibodies in disease pathogenesis, particularly in HIV and SLE. In 2017, her team first determined that autoimmunity impacts antiretroviral therapy outcomes in HIV without inducing autoimmune disease. This concept was later corroborated in studies on COVID-19. Her team is currently developing monoclonal autoantibodies and inhibitors to prevent anti-CD4 autoantibody binding, aiming to improve CD4+ T cell recovery and reduce morbidity in HIV patients. The second area of focus is the role of microbiomes in disease pathogenesis, including HIV, SLE, and drug abuse. She has identified the impact of disease-associated pathobionts on immune perturbations and disease progression, with findings validated in animal models. Her microbiome research is supported by R01DA055523.

TRAINING, PROFESSIONAL APPOINTMENTS

She currently serves on the Appointment, Promotion & Tenure (APT) committee in the Department of Microbiology and Immunology at the Medical University of South Carolina, a position she has held since 2024. She was promoted to Full Professor with tenure in the Department of Microbiology and Immunology, Division of Infectious Diseases, Department of Medicine at the same institution in 2023. She has been a Faculty Senator for the College of Medicine and a Research Health Scientist at the Ralph H. Johnson VA Medical Center since 2022. Additionally, she is a member of the Translational Science Laboratory IAC (2020-2022) and the MUSC College’s Curriculum Committee (2019-Present). She has held various positions at MUSC, including Associate Professor (2018-2022) and Assistant Professor (2012-2018) in the Department of Microbiology and Immunology. Since 2018, she has been a member of the Hollings Cancer Center at MUSC and has served on the award committee for the Advancement, Recruitment, and Retention of Women in Science. Her academic career began as an Instructor (2008-2012) and Research Associate (2002-2008) at Case Western Reserve University School of Medicine in Cleveland, OH.

AWARDS

She received her Chinese Board of Internal Medicine certification in Infectious Diseases in July 1997 and was certified as an Attending Medical Doctor in Infectious Diseases in November 1999 (No: 10203C089758). In July 1997, she also earned a Teacher Qualification from the Educational Institute, National Educational Committee in China (No: 971100071069382). Her licensure is from Beijing, China.

She has received several awards throughout her career, including the Laboratory Travel Grant from the American Association of Immunologists (AAI) in 2019, the MUSC High Impact Research Publication Award in 2019, and multiple travel grants from AAI for various international immunology congresses. She was awarded the Early Career Faculty Travel Grant by AAI and ECI in 2018 and 2017, and received the Travel Award and HIV Section Chair recognition at the 2016 International Congress of Immunology. In 2015, she was honored with the MUSC Foundation Developing Scholar Award and an Early Career Faculty Travel Grant from AAI. Her earlier achievements include multiple Young Investigator Awards from the 13th and 15th Conferences on Retroviruses and Opportunistic Infections (2006, 2008) and the Keystone Meeting on HIV Pathogenesis (2006, 2008). Additionally, she was recognized as an Outstanding Student Leader for five consecutive years during her medical school years from 1986 to 1991.

OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS

She has held several key professional roles and memberships throughout her career. Since 2024, she has been serving as a mentor for the American Society for Microbiology (ASM) Future Leaders Mentorship Fellowship (FLMF) Program. She is a member of the Society on NeuroImmune Pharmacology 2024 committee and has been a Treasurer Elect for the Association of Chinese Virologists in America from 2022 to 2024. She has been a member of the American Society for Microbiology (ASM) since 2021 and the Infectious Diseases Society of America (IDSA) since 2020. She has also been serving on the Editorial Board of the Journal of Neuroimmune Pharmacology since 2019 and is a member of the Society on NeuroImmune Pharmacology. Additionally, she has been part of the Society of Chinese Bioscientists in America (SCBA) and the American College of Rheumatology since 2018. She has contributed as an award committee member for the Advancement, Recruitment, and Retention of Women in Science at the Medical University of South Carolina since 2017 and is an associate member of the Hollings Cancer Center at MUSC.

She is also an active member of the MUSC Oral Health Center, College of Dental Medicine, and the Medical University of South Carolina College of Graduate Studies. Her previous memberships include being part of the American Association of Immunologists from 2011 to 2021, the Center for AIDS Research from 2008 to 2012, and the AIDS Clinic Trial Group since 2008. Her certification in Chinese Board of Internal Medicine in Infectious Diseases dates back to 1997, along with her teacher qualification from the Educational Institute, National Educational Committee, China.

CURRENT RESEARCH PROJECTS

She is currently leading several impactful research projects. As the Principal Investigator (PI) on R01DA059854 (9/30/2024-5/31/2029), funded by NIDA with a total of $3,924,302, she is studying the impacts of drug abuse-mediated inflammatory perturbations on affinity maturation of anti-CD4 autoantibodies and poor immune reconstitution from ART in HIV. This project aims to understand the role of cocaine in autoimmunity and immune recovery in HIV patients. Her role in this project is as PI (25% effort).

She is also a multiPI on R01DA059538 (9/30/2023-7/31/2028), with a total of $1,724,585 from NIDA, investigating host gene isoforms contributing to HIV persistence in cocaine users. The study focuses on identifying gene isoforms associated with HIV infection in elite controllers and its implications for cocaine users. Her role is PI (25% effort).

In addition, she is the PI on I01CX002422 (3/1/2022-2/28/2026), funded by the VA Medical Center CSRD Merit with a total of $1,195,899. This project examines the mechanism of autoreactive B cell-mediated immunological failure in HIV-infected individuals on antiretroviral therapy despite virologic suppression. She is focused on understanding the molecular mechanisms of anti-CD4 IgG-producing B cells and the pathologic effects of anti-CD4 autoantibodies. Her role is PI with 62.5% effort.

Additionally, she is involved as multiPI on R01DA055523 (9/30/2022-7/31/2027), with a total funding of $1,731,992, where she is working alongside Fitting to investigate the effects of microbiome-related mechanisms on H

 Publication